Enoxaparin Administration in Dialysis Patients with Myocardial Ischemia

Introduction to Enoxaparin Therapy

• The American College of Cardiology/American Heart Association recommends enoxaparin as a reasonable option for STEMI patients managed with fibrinolysis, with a Class IIa, Level of Evidence A recommendation 1
• For NSTEMI patients, enoxaparin is preferable to unfractionated heparin unless severe renal impairment or CABG is planned within 24 hours, with a Class IIa, Level of Evidence A recommendation 4

Critical Safety Principles

• The American College of Cardiology/American Heart Association guidelines explicitly state that switching between enoxaparin and unfractionated heparin in either direction causes harm, with a Class III recommendation 2, 3, 1, 4
• Once enoxaparin is initiated, commit to it and do not switch back to unfractionated heparin, as this significantly increases bleeding risk 1, 4

Dosing and Administration

• For dialysis patients with CrCl <30 mL/min, reduce enoxaparin to 1 mg/kg subcutaneously once daily instead of the standard twice-daily dosing 1, 5, 4
• Omit the initial 30 mg IV bolus typically used in younger patients, and standard twice-daily dosing should never be used in patients with CrCl <30 mL/min without dose reduction 1, 4

Monitoring and Reversal

• Monitor anti-Xa levels in all dialysis patients receiving enoxaparin, with peak levels checked 4 hours after administration, and target therapeutic anti-Xa range is 0.5-1.0 IU/mL for once-daily dosing 5, 4
• If bleeding complications occur requiring anticoagulation reversal, protamine sulfate can partially reverse enoxaparin, achieving approximately 60% reversal 1

Concomitant Therapy

• Continue aspirin regardless of bleeding risk, as the thrombotic risk in acute coronary syndrome outweighs bleeding risk, and aspirin dramatically reduces mortality, with a Class I, Level of Evidence A recommendation 1
• Administer clopidogrel 600 mg loading dose followed by 75 mg daily, or 150 mg daily for the first week in high-risk patients 1

Alternative Considerations

• Unfractionated heparin remains a valid alternative for dialysis patients requiring therapeutic anticoagulation, as it does not require renal dose adjustment and allows for better control, with an initial bolus of 60 U/kg IV and an infusion of 12 U/kg/hour adjusted to maintain aPTT at 1.5-2.0 times control 6, 5, 4